BioNTech (BNTX) News Today $113.08 +1.74 (+1.56%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Comparing Senti Biosciences (NASDAQ:SNTI) and BioNTech (NASDAQ:BNTX)December 19 at 2:47 AM | americanbankingnews.comBioNTech (NASDAQ:BNTX) Stock Price Down 1.3% - Time to Sell?BioNTech (NASDAQ:BNTX) Trading Down 1.3% - Should You Sell?December 18 at 2:42 PM | marketbeat.com3 No-Brainer Biotech Stocks to Buy With $200 Right NowDecember 18 at 5:44 AM | fool.comJ.P. Morgan Reaffirms Their Hold Rating on BioNTech SE (BNTX)December 17, 2024 | markets.businessinsider.comBioNTech (NASDAQ:BNTX) Shares Up 2.9% - Still a Buy?BioNTech (NASDAQ:BNTX) Trading 2.9% Higher - Here's What HappenedDecember 17, 2024 | marketbeat.comBarclays PLC Sells 50,453 Shares of BioNTech SE (NASDAQ:BNTX)Barclays PLC decreased its holdings in BioNTech SE (NASDAQ:BNTX - Free Report) by 37.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 83,253 shares of the company's stock after selling 50,453 shares during the quarteDecember 17, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Shares Down 2.3% - Time to Sell?BioNTech (NASDAQ:BNTX) Trading Down 2.3% - What's Next?December 16, 2024 | marketbeat.comExome Asset Management LLC Takes Position in BioNTech SE (NASDAQ:BNTX)Exome Asset Management LLC acquired a new position in BioNTech SE (NASDAQ:BNTX - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 34,552 shares of the company's stock, valued at approximately $4,104,000. BioNTech accountsDecember 14, 2024 | marketbeat.comY Intercept Hong Kong Ltd Invests $718,000 in BioNTech SE (NASDAQ:BNTX)Y Intercept Hong Kong Ltd purchased a new stake in BioNTech SE (NASDAQ:BNTX - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 6,046 shares of the company's stock, valued at approximately $718,000. A number of other institutional investoDecember 14, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Research Coverage Started at Wells Fargo & CompanyDecember 14, 2024 | americanbankingnews.comFDA Lifts Hold on BioNTech’s Key Cancer TrialDecember 13, 2024 | tipranks.comUS FDA lifts partial clinical hold on BioNTech cancer drug studyDecember 13, 2024 | reuters.comBioNTech (NASDAQ:BNTX) Stock Price Down 1.6% - Here's What HappenedBioNTech (NASDAQ:BNTX) Shares Down 1.6% - Here's WhyDecember 13, 2024 | marketbeat.comVestcor Inc Takes Position in BioNTech SE (NASDAQ:BNTX)Vestcor Inc bought a new stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 6,600 shares of the company's stock, valued at approximately $784,000. Several other hedDecember 13, 2024 | marketbeat.comCaptrust Financial Advisors Sells 8,909 Shares of BioNTech SE (NASDAQ:BNTX)Captrust Financial Advisors cut its position in BioNTech SE (NASDAQ:BNTX - Free Report) by 70.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,678 shares of the company's stock after selling 8,909 shares during the quarter. CaptDecember 13, 2024 | marketbeat.comJefferies Keeps Their Buy Rating on BioNTech SE (BNTX)December 12, 2024 | markets.businessinsider.comBioNTech (NASDAQ:BNTX) Stock Price Up 1.3% - Time to Buy?BioNTech (NASDAQ:BNTX) Stock Price Up 1.3% - Time to Buy?December 12, 2024 | marketbeat.comWells Fargo Initiates Coverage of BioNTech SE - Depositary Receipt () (BNTX) with Overweight RecommendationDecember 12, 2024 | msn.comBioNTech SE: Promising Developments in Triple-Negative Breast Cancer Amid Cautious OptimismDecember 11, 2024 | markets.businessinsider.comBioNTech (NASDAQ:BNTX) Stock Price Up 2.7% - Here's What HappenedBioNTech (NASDAQ:BNTX) Stock Price Up 2.7% - Here's What HappenedDecember 11, 2024 | marketbeat.comBioNTech SE’s Promising Future: Buy Rating Backed by Breakthrough Cancer Therapy and Expansive PipelineDecember 11, 2024 | markets.businessinsider.comBioNTech (NASDAQ:BNTX) Now Covered by Analysts at Wells Fargo & CompanyWells Fargo & Company initiated coverage on BioNTech in a research report on Wednesday. They issued an "overweight" rating and a $170.00 price target for the company.December 11, 2024 | marketbeat.com2 Healthcare Stocks to Buy Hand Over Fist and 1 to AvoidDecember 11, 2024 | fool.comBioNTech (NASDAQ:BNTX) Trading Down 0.7% - Here's WhyBioNTech (NASDAQ:BNTX) Stock Price Down 0.7% - Time to Sell?December 10, 2024 | marketbeat.comStrategic Combinations Propel BioNTech’s B7-H3 ADC BNT324 Amidst Competitive Landscape: Analyst ‘Buy’ RatingDecember 10, 2024 | markets.businessinsider.comBioNTech (NASDAQ:BNTX) Stock Price Down 1.6% - Here's WhyBioNTech (NASDAQ:BNTX) Stock Price Down 1.6% - Here's WhyDecember 9, 2024 | marketbeat.com2 No-Brainer Stocks to Buy Before the End of 2024December 9, 2024 | fool.com20,929 Shares in BioNTech SE (NASDAQ:BNTX) Acquired by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company bought a new stake in BioNTech SE (NASDAQ:BNTX - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 20,929 shares of the company's stock, valued atDecember 9, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Grows Stock Holdings in BioNTech SE (NASDAQ:BNTX)Charles Schwab Investment Management Inc. boosted its holdings in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 123.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 134,036 shaDecember 8, 2024 | marketbeat.comKrensavage Asset Management LLC Lowers Holdings in BioNTech SE (NASDAQ:BNTX)Krensavage Asset Management LLC decreased its stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 29.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 93,583 shares of the company's stockDecember 7, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Shares Up 4.4% - Should You Buy?BioNTech (NASDAQ:BNTX) Trading 4.4% Higher - Time to Buy?December 6, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Decreases Holdings in BioNTech SE (NASDAQ:BNTX)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its holdings in BioNTech SE (NASDAQ:BNTX - Free Report) by 20.4% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 184,334 shares of the company's stock after sellingDecember 6, 2024 | marketbeat.comTD Cowen Keeps Their Hold Rating on BioNTech SE (BNTX)December 5, 2024 | markets.businessinsider.comBioNTech (NASDAQ:BNTX) Shares Up 1.7% - Still a Buy?BioNTech (NASDAQ:BNTX) Trading Up 1.7% - Time to Buy?December 5, 2024 | marketbeat.comRedmile Group LLC Purchases Shares of 154,456 BioNTech SE (NASDAQ:BNTX)Redmile Group LLC purchased a new stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 154,456 shares of the company's stock, valued at approximately $18,345,000. RedmilDecember 5, 2024 | marketbeat.comPoint72 Asset Management L.P. Has $42.99 Million Stock Holdings in BioNTech SE (NASDAQ:BNTX)Point72 Asset Management L.P. trimmed its position in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 21.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 361,993 shares of the company's stock aftDecember 5, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Trading Down 0.3% - What's Next?BioNTech (NASDAQ:BNTX) Trading Down 0.3% - Here's What HappenedDecember 4, 2024 | marketbeat.comPolar Asset Management Partners Inc. Invests $14.83 Million in BioNTech SE (NASDAQ:BNTX)Polar Asset Management Partners Inc. acquired a new position in BioNTech SE (NASDAQ:BNTX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 124,900 shares of the company's stock, valued at aDecember 4, 2024 | marketbeat.com5 Top Stocks to Buy in DecemberDecember 4, 2024 | fool.comBioNTech SE (NASDAQ:BNTX) Shares Bought by Bamco Inc. NYBamco Inc. NY raised its stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) by 88.6% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 18,574 shares of the company's stock after buying an additional 8,724 shares during the period. Bamco Inc. NY's holDecember 4, 2024 | marketbeat.comPromising Oncology Developments and Stable COVID-19 Business Drive BioNTech SE’s Buy RatingDecember 3, 2024 | markets.businessinsider.comBioNTech (NASDAQ:BNTX) Trading Down 0.2% - Should You Sell?BioNTech (NASDAQ:BNTX) Shares Down 0.2% - Time to Sell?December 3, 2024 | marketbeat.comBridgewater Associates LP Invests $674,000 in BioNTech SE (NASDAQ:BNTX)Bridgewater Associates LP bought a new stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 5,673 shares of the company's stock, valued at approximatelDecember 3, 2024 | marketbeat.comBioNTech SE (BNTX) Receives a Buy from Morgan StanleyDecember 3, 2024 | markets.businessinsider.comBioNTech (NASDAQ:BNTX) Shares Up 0.5% - Here's WhyBioNTech (NASDAQ:BNTX) Trading Up 0.5% - Here's What HappenedDecember 2, 2024 | marketbeat.comBioNTech's (BNTX) Outperform Rating Reaffirmed at BMO Capital MarketsBMO Capital Markets reissued an "outperform" rating on shares of BioNTech in a research report on Monday.December 2, 2024 | marketbeat.comBioNTech SE (NASDAQ:BNTX) Sees Large Growth in Short InterestBioNTech SE (NASDAQ:BNTX - Get Free Report) was the recipient of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 2,470,000 shares, a growth of 22.3% from the October 31st total of 2,020,000 shares. Based on an average trading volume of 1,120,000 shares, the days-to-cover ratio is presently 2.2 days.December 1, 2024 | marketbeat.com8,721 Shares in BioNTech SE (NASDAQ:BNTX) Bought by Bellevue Group AGBellevue Group AG bought a new position in BioNTech SE (NASDAQ:BNTX - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 8,721 shares of the company's stock, valued at approximately $1,036,000. A numbeDecember 1, 2024 | marketbeat.comPoint72 Europe London LLP Purchases Shares of 27,231 BioNTech SE (NASDAQ:BNTX)Point72 Europe London LLP acquired a new stake in shares of BioNTech SE (NASDAQ:BNTX - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 27,231 shares of the company's stock, valued at approximately $3,234November 30, 2024 | marketbeat.comBioNTech (NASDAQ:BNTX) Stock Price Down 0.9% - What's Next?BioNTech (NASDAQ:BNTX) Shares Down 0.9% - Here's What HappenedNovember 29, 2024 | marketbeat.com Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin BNTX Media Mentions By Week BNTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼0.660.60▲Average Medical News Sentiment BNTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼711▲BNTX Articles Average Week Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News Today Takeda Pharmaceutical News Today Teva Pharmaceutical Industries News Today BeiGene News Today Moderna News Today Viatris News Today Summit Therapeutics News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Sarepta Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNTX Stock Alerts